Disposition pursuant to a tender of shares in a change of control transaction by Gordon Carl L of Theseus Pharmaceuticals
THRXDelisted Stock | USD 3.71 0.14 3.92% |
Slightly above 55% of Theseus Pharmaceuticals' investors are presently thinking to get in. The analysis of current outlook of investing in Theseus Pharmaceuticals suggests that some traders are interested regarding Theseus Pharmaceuticals' prospects. Theseus Pharmaceuticals' investing sentiment can be driven by a variety of factors including economic data, Theseus Pharmaceuticals' earnings reports, geopolitical events, and overall market trends.
Theseus |
Filed transaction by Theseus Pharmaceuticals I director. Disposition pursuant to a tender of shares in a change of control transaction
Read at finance.yahoo.com
Theseus Pharmaceuticals Fundamental Analysis
We analyze Theseus Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Theseus Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Theseus Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Working Capital
Working Capital Comparative Analysis
Theseus Pharmaceuticals is currently under evaluation in working capital category among its peers. Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
Theseus Pharmaceuticals Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Theseus Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Theseus Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Theseus Pharmaceuticals by comparing valuation metrics with similar companies.
Peers
Theseus Pharmaceuticals Related Equities
MRSN | Mersana Therapeutics | 8.47 | ||||
TERN | Terns Pharmaceuticals | 7.18 | ||||
RCUS | Arcus Biosciences | 2.84 | ||||
ERAS | Erasca | 2.17 | ||||
ELVN | Enliven Therapeutics | 1.97 | ||||
GLUE | Monte Rosa | 1.86 | ||||
IMRX | Immuneering Corp | 1.57 | ||||
PMVP | Pmv Pharmaceuticals | 1.42 | ||||
HOOK | Hookipa Pharma | 0.50 | ||||
BPMC | Blueprint Medicines | 0.99 | ||||
RLAY | Relay Therapeutics | 1.54 | ||||
DSGN | Design Therapeutics | 2.63 | ||||
CGEM | Cullinan Oncology | 2.91 | ||||
IPSC | Century Therapeutics | 3.53 | ||||
DAWN | Day One | 3.69 | ||||
XFOR | X4 Pharmaceuticals | 10.81 |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Other Consideration for investing in Theseus Stock
If you are still planning to invest in Theseus Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Theseus Pharmaceuticals' history and understand the potential risks before investing.
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Stocks Directory Find actively traded stocks across global markets |